Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program
舒尼替尼联合 FOLFIRI 方案与单纯 FOLFIRI 方案治疗化疗难治性晚期胃或下段食管腺癌患者：一项随机、安慰剂对照的 II 期 AIO 试验，并采用血清生物标志物方案
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-016-2736-9
Moehler, Markus; Gepfner-Tuma, Irina; Maderer, Annett; Thuss-Patience, Peter C; Ruessel, Joern; Hegewisch-Becker, Susanna; Wilke, Hansjochen; Al-Batran, Salah-Eddin; Rafiyan, Mohammad-Reza; Weißinger, Florian; Schmoll, Hans-Joachim; Kullmann, Frank; von Weikersthal, Ludwig Fischer; Siveke, Jens T; Weusmann, Jens; Kanzler, Stephan; Schimanski, Carl Christoph; Otte, Melanie; Schollenberger, Lukas; Koenig, Jochem; Galle, Peter R
